PureForm Global, Inc.
Simon Lapthorn is an experienced sales professional currently serving as Vice President of Sales at Pretty Woman USA LLC since February 2018 and Sales Manager at PureForm Global, Inc. since March 2019. Previously, Simon held the position of Sales Director at Simple Green UK from January 2017 to December 2022. Simon also served as Vice President EMEA at Pacific World from January 2002 to July 2016, overseeing sales and marketing for various brands in the region. Earlier career roles include Business Development Director at Gillette UK, Group Category Management Controller at Gillette Gruppe Deutschland, Customer Marketing Manager at Duracell GmbH, and Trade Sector Manager Grocery at Duracell Batteries Ltd.
This person is not in any teams
This person is not in any offices
PureForm Global, Inc.
PureForm is a biosciences company focused on the discovery and production of pure cannabinoids for use in treating disease and promoting wellness. PureForm uses its proprietary technology to produce rare cannabinoids that are safe, legal, and effective for wellness and pharmaceutical applications. Our synthetic platform can quickly and sustainably produce almost any molecule found in nature. Enabling superior supply chain economics while creating sustainable solutions for both natural and novel compounds. Our research and clean chemistry production platform enables a sustainable, safe, cost effective, commercial scale supply chain option for both pharmaceutical and consumer products companies to address widespread consumer adoption. PureForm uses Cyclic Terpene Assembly™ (CTA), it’s proprietary technology for assembling cannabinoids from naturally occurring terpenes. The Cannome™ is PureForm’s catalogue of cannabinoids - all pure molecules, synthesized using Natural Product Chemistry. PureForm CBD is PureForm’s first cannabinoid to go from bench to commercial scale cGMP production. PureForm’s proprietary platform is unlocking the potential of over 100 cannabinoids. Each cannabinoid is chirally pure and stereochemically identical to cannabinoids extracted from hemp and cannabis. PureForm has completed commercial scale-up of CBD and can produce metric ton quantities today. In addition to the production of cannabinoids found in hemp and cannabis, PureForm is also working on routes of synthesis to develop unique and novel compounds and cannabinoid-like derivatives targeting the endocannabinoid system that have the potential to be pharmaceutically relevant. Our Cyclic Terpene Assembly™ (CTA) technology delivers a high-performance alternative to agricultural and biosynthetic based production of molecules in a cost efficient and sustainable format.